Latest Raya Therapeutic News & Updates

See the latest news and media coverage for Raya. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Raya Therapeutic (Raya)

Biotechnology company developing treatments for ALS and other neurodegenerative diseases

rayatherapeutic.com
Headquarters
Montreal, Canada
Founded year
2019
Company type
Private company
Number of employees
5–10
Industry
Pharmaceuticals

Last updated

Latest news about Raya Therapeutic (Raya)

In short: Raya announced pipeline developments for neurodegenerative diseases and advanced multiple ALS compounds toward clinical trials.

Company announcements

Raya

Raya Therapeutic unveils Raya CARES pipeline

The pipeline features five clinical-stage compounds with unique mechanisms targeting ALS, PD, and neurodegenerative diseases. Each has established safety data. Raya plans Phase 2/3 trials within 12-18 months.

Raya

Raya announces compound selection for EXPERTS-ALS trial

One of five clinical-stage compounds advances toward ALS approval in University of Sheffield-led platform trial. Positive data could lead to registration trial.

Unlock all announcements with a

Media coverage

Kelo

Raya Therapeutic Announces Selection of one of its 5 compounds onto the EXPERTS-ALS Clinical Platform Trial

Positive data from this clinical study could lead to a registration trial of the compound for the treatment of ALS/MND. MONTREAL, QUEBEC, CANADA, September 2...

Unlock all articles with a

Never miss news about Raya

Track Raya and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.